What is the Connection between Hemoglobin Levels and Quality of Life in MDS?

By Jamie Koprivnikar, MD, Thomas LeBlanc, MD, MA, Andrew Brunner, MD - Last Updated: February 18, 2025

Thomas LeBlanc, MD, MA, of Duke Cancer Institute continues a discussion of myelodysplastic syndromes with Jamie Koprivnikar, MD, of Hackensack University Medical Center and Andrew Brunner, MD, of Massachusetts General Hospital. Subjects explored in this segment include patient reported outcomes, transfusion dependence, and time toxicity in patients being treated for lower-risk disease.

Advertisement

Advertisement
Advertisement
Advertisement